Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves

Journal of the American College of Cardiology

Volumn 33, Issue 6, 1999, Pages 1637-1641

  Vitale, Nicola ^a,c,d   De Feo, Marisa ^a   De Santo, Luca Salvatore ^a   Pollice, Alessio ^b   Tedesco, Nicola ^b   Cotrufo, Maurizio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c FREEMAN HOSPITAL   (United Kingdom)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; EMBRYOPATHY; FEMALE; HEART VALVE PROSTHESIS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRIORITY JOURNAL; SPONTANEOUS ABORTION; STILLBIRTH; THROMBOSIS;

ABNORMALITIES, DRUG-INDUCED; ANTICOAGULANTS; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL DEATH; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFANT, NEWBORN; INTERNATIONAL NORMALIZED RATIO; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSTHESIS FAILURE; THROMBOSIS; WARFARIN;

EID: 0033133401     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00044-3     Document Type: Article

References (17)

1. Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, editors. Haemostasis and Thrombosis. London: Churchill Livingstone, 1994:570-83.
2. Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-3.
3. Born D, Martinez EE, Almeida, PAM, et al. Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992;124:413-7.
4. Elkayam U. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704-6.
5. Hanania G, Thomas D, Michel PL, et al. Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 1994;15:1651-8.
6. Gohlke-Barwolf C, Acar J, Oakley CM, et al. Guide-lines for prevention of thrombo-embolic events in valvular heart disease. Eur Heart J 1995;16:1320-30.
7. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201.
8. Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74:107-11.
9. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-703.
10. Cotrufo M, de Luca TSL, Calabrò R, et al. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses. Eur J Cardiothorac Surg 1991;3:300-5.
11. Sareli P, England MJ, Berk MR, et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 1989;63:1462-5.
12. Quick A. Experimentally induced changes in the prothrombin level of the blood. Prothrombin concentration of newborn pups of a mother given dicoumarol before parturition. J Biol Chem 1946;164:371-4.
13. Krauss AP, Perlow A, Singer K. Danger of dicoumarol treatment in pregnancy. JAMA 1949;139:758-61.
14. Hirsh J, Cade JF, Gallus AS. Fetal effects of coumadin administered during pregnancy. Blood 1970;623-7.
15. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
16. Pauli RM. Mechanism of bone and cartilage maldevelopment in the warfarin embryopathy. Pathol Immunopathol Res 1988;7:107-12.
17. Milano A, Bortolotti U, Mazzucco A, et al. Heart valve replacement with the Sorin tilting-disc prosthesis. A 10-year experience. J Thorac Cardiovasc Surg 1992;103:267-5.